EMEA Committee Agrees To Expedite Flu Vaccine Reviews
This article was originally published in The Pink Sheet Daily
Executive Summary
Accelerated review of flu vaccine “core dossiers” would allow approval within days of strain identification.
You may also be interested in...
GSK Submits Pandemic Flu Vaccine Under EU Accelerated Review Program
Submission marks the first use of the European Medicines Agency’s “core dossier” accelerated review program.
GSK Submits Pandemic Flu Vaccine Under EU Accelerated Review Program
Submission marks the first use of the European Medicines Agency’s “core dossier” accelerated review program.
Sanofi-Pasteur H5N1 Avian Flu Vaccine Stimulates Immune Response In Trial
The 300-subject study showed that a regimen of two 30 mcg doses with adjuvant was safe and well tolerated.